Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BactiQuant AS's EBIT per Share for the
six
months ended in Dec. 2025 was €-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.05.
During the past 3 years, the average EBIT per Share Growth Rate was 13.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -28.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for BactiQuant AS's EBIT per Share or its related term are showing as below:
FRA:9JX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -231.4 Med: -46.55 Max: 13.8
Current: 13.8
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of BactiQuant AS was 13.80% per year. The lowest was -231.40% per year. And the median was -46.55% per year.
FRA:9JX's 3-Year EBIT Growth Rate is ranked better than 63.39% of 2499
companies
in the Industrial Products industry
Industry Median: 4.7
vs FRA:9JX: 13.80
BactiQuant AS's EBIT for the
six
months ended in Dec. 2025 was €-0.81 Mil.
BactiQuant AS (FRA:9JX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
BactiQuant AS EBIT per Share Related Terms
BactiQuant AS EBIT per Share Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS (FRA:9JX) has a EBIT per Share of €-0.05 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BactiQuant AS and its competitors. According to the industry distribution chart, BactiQuant AS ranks #915 out of 2499 companies in the Industrial Products industry, placing it in the top 36.6%.
Is BactiQuant AS's EBIT per Share too high?
BactiQuant AS's current EBIT per Share is €-0.05. Based on the distribution chart, BactiQuant AS ranks #915 out of 2499 companies in the Industrial Products industry, which is above the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's EBIT per Share compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #915 out of 2499 companies for EBIT per Share. This puts BactiQuant AS in the upper half of its industry. The industry median EBIT per Share is 4.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Industrial Products company?
The median EBIT per Share among Industrial Products companies is 4.70, based on 2,499 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median EBIT per Share is 4.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current EBIT per Share is €-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
BactiQuant AS (FRA:9JX) has a current EBIT per Share of €-0.05. The stock's GF Value™ is €0.29, compared to a current price of €0.26 — trading 9.3% below its estimated fair value. The current EBIT per Share is €-0.05. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For BactiQuant AS (FRA:9JX), the current EBIT per Share is €-0.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (FRA:9JX) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be undervalued.
The current stock price of €0.26 is trading 9.3% below its estimated GF Value™ of €0.29.
Key valuation signals for FRA:9JX:
EBIT per Share: €-0.05
GF Value™: €0.29 vs. price of €0.26 (9.3% below fair value)
No single metric tells the full story. See the FRA:9JX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score
Get the complete analysis for FRA:9JX
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:9JX has been successfully added to your 
